GUTS
Fractyl Health Inc.

1,763
Mkt Cap
$60.48M
Volume
1.67M
52W High
$3.03
52W Low
$0.3772
PE Ratio
-0.19
GUTS Fundamentals
Price
$0.4413
Prev Close
$0.4366
Open
$0.4349
50D MA
$0.893
Beta
1.26
Avg. Volume
4.87M
EPS (Annual)
-$1.44
P/B
-18.36
Rev/Employee
$869.16
$95.47
Loading...
Loading...
News
all
press releases
Fractyl Health, Inc. (GUTS) Moves to Buy: Rationale Behind the Upgrade
Fractyl Health, Inc. (GUTS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·5d ago
News Placeholder
More News
News Placeholder
Rosalind Advisors Inc. Takes Position in Fractyl Health, Inc. $GUTS
Rosalind Advisors Inc. purchased a new position in Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·9d ago
News Placeholder
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) has been given an average rating of "Hold" by the five brokerages that are currently covering the stock, MarketBeat.com reports. One equities...
MarketBeat·20d ago
News Placeholder
Fractyl Health, Inc. (GUTS) Loses 77.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Fractyl Health, Inc. (GUTS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Zacks·26d ago
News Placeholder
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday
Fractyl Health (NASDAQ:GUTS) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...
MarketBeat·27d ago
News Placeholder
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Increases By 22.6%
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a large growth in short interest in January. As of January 30th, there was short interest totaling 14,901,084 shares, a growth...
MarketBeat·1mo ago
News Placeholder
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) have received a consensus rating of "Hold" from the five brokerages that are currently covering the firm, Marketbeat.com reports. One...
MarketBeat·1mo ago
News Placeholder
Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights GUTS
The DJS Law Group announces that it is investigating claims on behalf of investors of Fractyl Health, Inc. (Fractyl Health or the Company) (NASDAQ: GUTS) for violations of the securities laws...
Business Wire·2mo ago
News Placeholder
Fractyl Health Showcases 6-Month REMAIN-1 Data as Revita Curbs Post-GLP-1 Weight Regain
Fractyl Health (NASDAQ:GUTS) presented prospective, randomized, double-blind, controlled six-month data from its REMAIN-1 midpoint cohort pilot study, highlighting results the company said support...
MarketBeat·2mo ago
News Placeholder
Why Did GUTS Stock Plummet Today Despite Positive Gut Therapy Midterm Study?
Six-month data from 40 participants suggest that Revita helps limit weight regain after GLP-1 discontinuation.
Stocktwits·2mo ago
<
1
2
...
>

Latest GUTS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.